Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID | D09NFX | ||||
| Former ID | DNC010428 | ||||
| Drug Name | Nicotinaldehyde O-4-propoxyphenylcarbamoyl oxime | ||||
| Drug Type | Small molecular drug | ||||
| Indication | Discovery agent | Investigative | [530604] | ||
| Formula | C16H17N3O3 | ||||
| Canonical SMILES | CCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CN=CC=C2 | ||||
| InChI | 1S/C16H17N3O3/c1-2-10-21-15-7-5-14(6-8-15)19-16(20)22-18-12-13-4-3-9-17-11-13/h3-9,11-12H,2,10H2,1H3,(H,19,20)/b18-12+ | ||||
| InChIKey | RKEOSRSRXNLQCF-LDADJPATSA-N | ||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530604] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
